Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors

Figure 5

Kaplan-Meier curve of PFS (a) and OS (b) comparing ≤3 lines and >3 lines of pyrotinib-containing treatments.

(a)

(b)